Covaxin WHO approval

The technical advisory group of the World Health Organisation on October 26 sought “additional clarifications” from Bharat Biotech to conduct a final “risk-benefit assessment” for Emergency Use Listing of its COVID-19 vaccine.

The statement came hours after WHO official Dr Margaret Harris had said that a recommendation was expected within the next 24 hours.


Leave a Reply

Your email address will not be published. Required fields are marked *